Praxis Precision Medicines Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Praxis Precision Medicines, Inc. (PRAX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-182.82-123.28-214.03-167.06-61.82
Depreciation & Amortization0.360.432.170.180.05
Stock Based Compensation41.3624.8628.5922.695.21
Change in Working Capital10.92-14.03-1.0316.133.24
Change in Accounts Payable6.71-8.863.897.270.96
Change in Other Working Capital3.43-2.73-10.678.872.28
Other Operating Activities3.430.8427.841.410.70
Net Cash from Operating Activities-131.76-111.14-185.04-124.55-52.62
Investing Activities
Capital Expenditures0.00-0.050.44-1.050.00
Purchases of Investments-371.5239.0097.33-139.470.00
Sales/Maturities of Investments123.0339.0097.3324.700.00
Net Cash from Investing Activities-248.4938.9596.89-140.520.00
Financing Activities
Common Stock Issued512.0092.01-0.26108.16200.97
Common Stock Repurchased-0.31-0.14-0.260.000.00
Other Financing Activities-0.31-0.14-0.26-0.580.00
Net Cash from Financing Activities514.3291.8710.47107.59304.42
Summary
Net Change in Cash134.0719.69-77.69-157.49251.79
Cash at Beginning of Period81.7262.03139.72297.2145.42
Cash at End of Period215.79-71.9162.03139.72297.21
Free Cash Flow-131.76-111.19-185.49-125.60-52.62